Component
Human-cell fatty-acid oxidation during impaired CoA import
Human-cell fatty-acid oxidation during impaired CoA import
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Combined SLC25A16/SLC25A42 deletion impaired fatty-acid oxidation and shifted TCA labeling toward reductive routes.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
- experimental_condition
- Control cells deleted · Human mitochondrial CoA transporter SLC25A16 Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Control cells deleted · Human mitochondrial coenzyme A transporter SLC25A42 Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "SLC25A16 and SLC25A42 double knockout", "comparator": "Control cells", "endpoint": "Combined SLC25A16/SLC25A42 deletion impaired fatty-acid oxidation and shifted TCA labeling toward reductive routes.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "human-slc25a16", "state": "deleted"}, {"entity_slug": "slc25a42", "state": "deleted"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- K562 and HeLa cells; mitochondrial metabolomics, respiration and 13C5-glutamine tracing.
- interpretation_status
- Source-derived curation with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Acetyl-L-carnitine collection; exact intervention and molecular form govern interpretation. · Acetyl-L-carnitine
- plain_language
- Combined SLC25A16/SLC25A42 deletion impaired fatty-acid oxidation and shifted TCA labeling toward reductive routes.
- primary_references
- Cellular pan-chain acyl-CoA profiling reveals SLC25A42/SLC25A16 in mitochondrial CoA import and metabolism. | https://pubmed.ncbi.nlm.nih.gov/40925986/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC12460162/ | https://doi.org/10.1038/s42255-025-01358-y
- source_locator
- Reviewed reference coa-import-fao; Long-chain acylcarnitines accumulated while free CoA fell. More acyl carrier is not equivalent to restored matrix CoA. ALCAR supplementation was not tested as rescue in this comparison.
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Acetyl-L-carnitine: detailed mechanisms of action (reviewed 6 October 2026) · lines 68–74
AI-assisted original review of primary studies and clearly identified official records. Exact primary access is stated; no independent replication is claimed. · supports · K562 and HeLa cells; mitochondrial metabolomics, respiration and 13C5-glutamine tracing. · Recorded from source · Recorded from source
### coa-import-fao Combined SLC25A16/SLC25A42 deletion impaired fatty-acid oxidation and shifted TCA labeling toward reductive routes. Long-chain acylcarnitines accumulated while free CoA fell. More acyl carrier is not equivalent to restored matrix CoA. ALCAR supplementation was not tested as rescue in this comparison. Model and exposure: K562 and HeLa cells; mitochondrial metabolomics, respiration and 13C5-glutamine tracing. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Cellular pan-chain acyl-CoA profiling reveals SLC25A42/SLC25A16 in mitochondrial CoA import and metabolism. | 2025 | https://pubmed.ncbi.nlm.nih.gov/40925986/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC12460162/ | https://doi.org/10.1038/s42255-025-01358-y | Access: Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.